Patents by Inventor Derek Dean Sloan

Derek Dean Sloan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Multispecific antibodies that target HIV GP120 and CD3
    Patent number: 11597759
    Abstract: Multispecific antibodies (e.g., bispecific antibodies) that bind to HIV gp120 and CD3 are disclosed. Also disclosed are methods of using such antibodies to treat or prevent HIV infection.
    Type: Grant
    Filed: May 6, 2020
    Date of Patent: March 7, 2023
    Assignee: GILEAD SCIENCES, INC.
    Inventors: Tomas Cihlar, Joshua Goldsmith, George Kukolj, Craig S. Pace, Doug Rehder, Matthew R. Schenauer, Derek Dean Sloan, Heather Theresa Stephenson, Nathan D. Thomsen
  • MULTISPECIFIC ANTIBODIES THAT TARGET HIV GP120 AND CD3
    Publication number: 20200377592
    Abstract: Multispecific antibodies (e.g., bispecific antibodies) that bind to HIV gp120 and CD3 are disclosed. Also disclosed are methods of using such antibodies to treat or prevent HIV infection.
    Type: Application
    Filed: May 6, 2020
    Publication date: December 3, 2020
    Inventors: Tomas Cihlar, Joshua Goldsmith, George Kukolj, Craig S. Pace, Doug Rehder, Derek Dean Sloan, Heather Theresa Stephenson, Nathan D. Thomsen
  • MODULATORS OF TOLL-LIKE RECEPTORS FOR THE TREATMENT OF HIV
    Publication number: 20180263985
    Abstract: Provided are methods, uses, pharmaceutical regimens, pharmaceutical compositions, and kits comprising modulators of TLR8 and pharmaceutically acceptable salts thereof, useful in treating HIV infections.
    Type: Application
    Filed: September 13, 2016
    Publication date: September 20, 2018
    Inventors: ROMAS GELEZIUNAS, JOSEPH E. HESSELGESSER, JASMINE KAUR, JEFFREY PATRICK MURRY, DEREK DEAN SLOAN
  • Compounds and combinations for the treatment of HIV
    Patent number: 10059697
    Abstract: Provided are compounds, compositions, combinations, kits, uses, and methods for treating HIV in a human being using such compounds or combinations with proteasome inhibitors.
    Type: Grant
    Filed: September 29, 2016
    Date of Patent: August 28, 2018
    Assignee: Gilead Sciences, Inc.
    Inventors: Tomas Cihlar, Michael Graupe, Yunfeng Eric Hu, Jeffrey Patrick Murry, Derek Dean Sloan, George Stepan, Helen Yu
  • COMPOUNDS AND COMBINATIONS FOR THE TREATMENT OF HIV
    Publication number: 20170114048
    Abstract: Provided are compounds, compositions, combinations, kits, uses, and methods for treating HIV in a human being using such compounds or combinations with proteasome inhibitors.
    Type: Application
    Filed: September 29, 2016
    Publication date: April 27, 2017
    Inventors: Tomas Cihlar, Michael Graupe, Yunfeng Eric Hu, Jeffrey Patrick Murry, Derek Dean Sloan, George Stepan, Helen Yu
  • MODULATORS OF TOLL-LIKE RECEPTORS FOR THE TREATMENT OF HIV
    Publication number: 20170071944
    Abstract: Provided are methods, uses, pharmaceutical regimens, pharmaceutical compositions, and kits comprising modulators of TLR8 and pharmaceutically acceptable salts thereof, useful in treating HIV infections.
    Type: Application
    Filed: September 13, 2016
    Publication date: March 16, 2017
    Inventors: ROMAS GELEZIUNAS, Joseph E. Hesselgesser, Jasmine Kaur, Jeffrey Patrick Murry, Derek Dean Sloan